IR-Med (IRME) Shares Outstanding (2020 - 2025)

IR-Med's Shares Outstanding history runs 6 years deep, the most recent figure standing at $77.2 million for Q2 2025.

• In Q2 2025, Shares Outstanding rose 9.25% year-over-year to $77.2 million; the TTM figure through Jun 2025 stood at $77.2 million (up 9.25% YoY), while the FY2024 annual figure was $71.0 million, up 1.54% from the prior year.
• Shares Outstanding came in at $77.2 million for Q2 2025 at IR-Med, up from $72.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $77.2 million in Q2 2025 to a low of $64.0 million in Q1 2021.
• A 5-year average of $68.8 million and a median of $69.3 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding soared 111.61% in 2021 and advanced 0.98% in 2022, its largest moves.
• IR-Med's Shares Outstanding stood at $64.6 million in 2021, then climbed by 6.51% to $68.8 million in 2022, then increased by 1.63% to $69.9 million in 2023, then rose by 1.54% to $71.0 million in 2024, then advanced by 8.77% to $77.2 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $77.2 million, $72.0 million, and $71.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison